Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

50.10
-1.4500-2.81%
Post-market: 50.06-0.0444-0.09%18:35 EDT
Volume:1.34M
Turnover:67.31M
Market Cap:4.84B
PE:-10.53
High:51.11
Open:51.01
Low:49.77
Close:51.55
52wk High:75.06
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:0.69
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:2.77
PE(LYR):-7.74

Loading ...

Review & Preview: Birthday Bull

Dow Jones
·
Yesterday

Movement Alert|CRISPR Therapeutics AG Rises 5.31% in Regular Trading, BofA Adjusts Target Price Maintaining Buy Rating

Market Focus
·
Oct 09

BofA Adjusts Price Target on CRISPR Therapeutics to $81 From $82, Keeps Buy Rating

MT Newswires Live
·
Oct 09

Crispr Therapeutics General Counsel James R. Kasinger Disposes of 1,990 Common Shares Worth $119,481.19

Reuters
·
Oct 09

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026

GlobeNewswire
·
Oct 08

Wells Fargo Sticks to Its Hold Rating for Crispr Therapeutics AG (CRSP)

TIPRANKS
·
Oct 05

Crispr Therapeutics Presents Phase 1 Zugo-Cel Data in Refractory Systemic Sclerosis at ACR Convergence 2026

Reuters
·
Oct 02

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot

Tech News Roundup
·
Oct 02

CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base

Simply Wall St.
·
Oct 02

ToolGen Raises KRW 19.5 Billion to Fund CRISPR Patent Battles and R&D

TIPRANKS
·
Sep 28

Snowflake, Palo Alto, Dell, GameStop, Crispr Insider Shock

TIPRANKS
·
Sep 26

Crispr Therapeutics General Counsel James R. Kasinger Disposes of Common Shares Worth $626,459.6

Reuters
·
Sep 25

Editas slips amid pressure on gene-editing sector after Anthropic update

TIPRANKS
·
Sep 24

Claude discovers novel enzyme system with CRISPR-like repeats

TIPRANKS
·
Sep 24

Crispr Therapeutics Director Ali Behbahani Disposes of Common Shares Worth $780,649.24

Reuters
·
Sep 22

Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi

TIPRANKS
·
Sep 16

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
Sep 08

Arm's Haas: AI Could Cure Cancer In Our Lifetime — If The Industry Can Build Enough Chips

AI Industry Frontlines
·
Sep 08

CRISPR Therapeutics (CRSP) Extends CTX310 Durability, Is The Stock Still Cheap?

Simply Wall St.
·
Sep 03